#1 Clinical Trials Search in Europe

Ciprofloxacin Hydrochloride

This article examines the use of Ciprofloxacin Hydrochloride, a widely-used antibiotic, in various clinical trials. These studies aim to evaluate its effectiveness in treating different medical conditions, including ear infections, prostate issues, and urinary tract infections. The trials also compare Ciprofloxacin Hydrochloride to other treatments and assess its safety profile.

Table of Contents

What is Ciprofloxacin Hydrochloride?

Ciprofloxacin Hydrochloride, often simply called ciprofloxacin, is an antibiotic medication used to treat various bacterial infections[1]. It belongs to a class of antibiotics known as fluoroquinolones. Ciprofloxacin is also known by other names, including CF and Cipro HC[5][3].

Medical Uses of Ciprofloxacin

Ciprofloxacin is used to treat a wide range of bacterial infections, including:

  • Dysentery: A type of intestinal inflammation that causes severe diarrhea with blood or mucus[1]
  • Prostate infections: Including chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)[5]
  • Urinary tract infections (UTIs): Infections affecting any part of the urinary system[4]
  • Otitis externa: Also known as swimmer’s ear, an infection of the outer ear canal[3]

How Ciprofloxacin Works

Ciprofloxacin works by inhibiting two important enzymes in bacteria: DNA-gyrase and topoisomerase IV. These enzymes are crucial for bacterial DNA replication and cell division. By blocking these enzymes, ciprofloxacin prevents bacteria from growing and multiplying, effectively stopping the infection[1].

How Ciprofloxacin is Administered

Ciprofloxacin can be administered in various ways, depending on the type and location of the infection:

  • Oral tablets: Usually taken twice daily for a specified period[5]
  • Intravenous (IV) injection: Used in hospital settings for more severe infections[4]
  • Ear drops: Used for ear infections, often combined with other medications like hydrocortisone[3]

The dosage and duration of treatment can vary depending on the specific condition being treated and the patient’s individual factors.

Effectiveness of Ciprofloxacin

The effectiveness of ciprofloxacin can vary depending on the specific condition being treated. For example:

  • In treating dysentery, ciprofloxacin has been shown to be effective and is often used as a standard treatment[1]
  • For chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a study found that ciprofloxacin was not significantly effective in reducing symptoms compared to a placebo[5]
  • In preventing urinary tract infections after certain medical procedures, ciprofloxacin has shown promise as a preventive measure[4]

Potential Side Effects

Like all medications, ciprofloxacin can cause side effects. Common side effects may include nausea, diarrhea, and headache. More serious side effects, though rare, can include tendon problems, nerve damage, and severe allergic reactions. It’s important to discuss potential side effects with your healthcare provider[5].

Ongoing Research and Clinical Trials

Researchers continue to study ciprofloxacin to better understand its effectiveness and potential new uses. Some areas of ongoing research include:

  • Comparing ciprofloxacin to other antibiotics for treating dysentery in children[1]
  • Investigating the use of ciprofloxacin in combination with other drugs for treating chronic prostatitis[5]
  • Studying the effectiveness of ciprofloxacin in preventing infections after certain medical procedures[4]
  • Comparing different formulations of ciprofloxacin for treating ear infections[3]

These ongoing studies help healthcare providers better understand how to use ciprofloxacin effectively and safely for various conditions.

Condition Trial Design Ciprofloxacin Hydrochloride Form Key Outcomes Measured
Otitis Externa Randomized, double-blind Ear drops (with hydrocortisone) Reduction in pain, swelling, and otorrhea
Chronic Prostatitis/Chronic Pelvic Pain Syndrome Randomized, double-blind, factorial Oral tablets Change in NIH-CPSI score, quality of life measures
Urinary Tract Infection Prevention (before SWL) Randomized, controlled Intravenous injection Rate of post-procedure urinary tract infections
Prostate-Specific Antigen (PSA) Variability Randomized, placebo-controlled Oral tablets Changes in PSA levels
Burns with Bacterial Infections Non-randomized, multi-center Intravenous injection Plasma levels and pharmacokinetics

FAQ

  • What is Ciprofloxacin Hydrochloride? Ciprofloxacin Hydrochloride is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called fluoroquinolones and works by stopping the growth of bacteria.
  • What conditions are being studied using Ciprofloxacin Hydrochloride in these clinical trials? The clinical trials are studying the use of Ciprofloxacin Hydrochloride in treating conditions such as otitis externa (outer ear infection), chronic prostatitis/chronic pelvic pain syndrome, urinary tract infections, and as a preventive measure before shock wave lithotripsy for kidney stones.
  • How is Ciprofloxacin Hydrochloride administered in these trials? Depending on the trial, Ciprofloxacin Hydrochloride is administered in various forms, including ear drops, oral tablets, and intravenous injections. The dosage and frequency vary based on the condition being treated.
  • Are there any side effects associated with Ciprofloxacin Hydrochloride? While specific side effects are not detailed in the provided trial information, all medications can have potential side effects. In these trials, researchers are monitoring for any adverse effects as part of their safety assessments.
  • How do researchers measure the effectiveness of Ciprofloxacin Hydrochloride in these trials? Researchers use various methods to measure effectiveness, including symptom reduction (such as pain or swelling), bacterial culture results, changes in specific symptom scores (like the NIH-Chronic Prostatitis Symptom Index), and overall patient-reported improvements.

Ongoing Clinical Trials on Ciprofloxacin Hydrochloride

  • Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway Sweden

  • Study on Adjusted Ciprofloxacin Dosing for Patients with Kidney Impairment and Bacterial Infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effectiveness of Autovaccines Compared to Antibiotics for Patients with Hip or Knee Prosthesis Infections

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia Czechia Denmark Greece Italy +2

  • Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of SpectraCure P18 System and Verteporfin for Treating Localized Prostate Cancer in Men

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Otitis Externa: An infection of the outer ear canal, also known as swimmer's ear. It can cause pain, swelling, and discharge from the ear.
  • Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A condition characterized by long-term pain or discomfort in the pelvic area, often associated with urinary symptoms and sexual dysfunction.
  • Tympanostomy Tube: A small tube inserted into the eardrum to allow air into the middle ear and prevent fluid buildup.
  • Otorrhea: Discharge from the ear, often associated with ear infections.
  • Shock Wave Lithotripsy (SWL): A non-invasive treatment that uses shock waves to break up kidney stones into smaller pieces that can pass more easily through the urinary tract.
  • Bacteriuria: The presence of bacteria in the urine, which may or may not cause symptoms.
  • NIH-Chronic Prostatitis Symptom Index (NIH-CPSI): A questionnaire used to assess the severity of symptoms in men with chronic prostatitis/chronic pelvic pain syndrome.
  • Placebo: An inactive substance or treatment used in clinical trials to compare the effects of a drug against no treatment.
  • Double-blind Trial: A study design where neither the participants nor the researchers know who is receiving the actual treatment and who is receiving a placebo.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.

References

  1. https://clinicaltrials.gov/study/NCT03854929
  2. https://clinicaltrials.gov/study/NCT03643198
  3. https://clinicaltrials.gov/study/NCT00980876
  4. https://clinicaltrials.gov/study/NCT01873690
  5. https://clinicaltrials.gov/study/NCT04552431